Antibacterial Composition

US2024284904A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2024284904-A1
Application numberUS-202218563694-A
CountryUS
Kind codeA1
Filing dateSep 28, 2022
Priority dateOct 21, 2021
Publication dateAug 29, 2024
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An antibacterial composition including a compound represented by the disclosed formula 1 and having an antibacterial activity of 80% or more as measured by the disclosed method 1, against at least one strain of gram-positive bacteria, gram-negative bacteria, and fungus. Since the antibacterial composition includes a hydrophilic functional group and a hydrophobic functional group at the same time, it is advantageous for imparting antibacterial properties.

First claim

Opening claim text (preview).

1 . An antibacterial composition including one or more compounds represented by formula 1 below and having an antibacterial activity of 80% or more, as measured by method 1 below, against at least one strain of gram-positive bacteria, gram-negative bacteria, and fungus: wherein, L1 and L2 are the same as or different from each other, and are each independently a direct bonds a substituted or unsubstituted alkylene group having 1 to 4 carbon atoms, or a substituted or unsubstituted arylene group having 6 to 30 carbon atoms; A is hydrogen, or a substituted or unsubstituted alkyl group having 1 to 3 carbon atoms-; n is an integer of 0 to 4; R1 and R2 are the same as or different from each other, and each independently a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, and at least one of R1 and R2 is a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms; and R3 is an alkyl group having 4 to 20 carbon atoms, wherein when n is 2 or more, As having n of 2 or more are the same as or different from each other; and [Method 1] after putting 25 mL of a broth-type medium inoculated with 3,000 CFU/mL of bacteria in a 50 mL conical tube, 0.015 g of the antibacterial composition i added and suspended, and a sufficiently mixed solution is cultured for 16 hours in a shaking water bath maintained at 35° C., and after diluting the cultured solution to 1/5 using 1×PBS buffer solution, an absorbance is measured using a UV/Vis spectrophotometer, and the measured absorbance is compared with the solution cultured without addition of the antibacterial composition to calculate the antibacterial activity, which is a bacteriostatic reduction rate, by an equation as follows: Antibacterial ⁢ activity ⁢ ( % ) = ( 1 - A sample / A Reference ) × 100 A sample = Absorbance ⁢ of ⁢ medium ⁢ solution ⁢ cultured ⁢ with ⁢ addition ⁢ of ⁢ antibacterial ⁢ composition A Reference = Absorbance ⁢ of ⁢ medium ⁢ solution ⁢ cultured ⁢ without ⁢ addition ⁢ of ⁢ antibacterial ⁢ composition 2 . The antibacterial composition of claim 1 , wherein the antibacterial activity is 90% or more. 3 . The antibacterial composition of claim 1 , wherein the gram-positive bacteria are any one selected from Enterococcus faecalis, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogene, Enterococcus faecium , and Lactobacillus lactis. 4 . The antibacterial composition of claim 1 , wherein the gram-negative bacteria are any one selected from Proteus mirabilis, Escherichia coli, Salmonella typhi, Pseudomonas aeruginosa, Vibrio cholerae , and Enterobacter cloacae. 5 . The antibacterial composition of claim 1 , wherein at least one of the R1 and R2 is an unsubstituted alkyl group having 1 to 4 carbon atoms. 6 . The antibacterial composition of claim 1 , wherein the R3 is an unsubstituted alkyl group having 4 to 16 carbon atoms. 7 . The antibacterial composition of claim 1 , wherein, when the R1 and R2 are the same as or different from each other and each independently a methyl group or an ethyl group, the R3 is an alkyl group having 4 to 16 carbon atoms. 8 . The antibacterial composition of claim 1 , wherein the L1 is a direct bond. 9 . The antibacterial composition of claim 1 , wherein the L2 is a methylene group. 10 . The antibacterial composition of claim 1 , wherein the compound represented by formula 1 above is any one selected from the group consisting of structures as follows:

Assignees

Inventors

Classifications

  • Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change · CPC title

  • Amines · CPC title

  • Homopolymers or copolymers of aromatic monomers containing elements other than carbon and hydrogen · CPC title

  • Amines · CPC title

  • Fungicides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2024284904A1 cover?
An antibacterial composition including a compound represented by the disclosed formula 1 and having an antibacterial activity of 80% or more as measured by the disclosed method 1, against at least one strain of gram-positive bacteria, gram-negative bacteria, and fungus. Since the antibacterial composition includes a hydrophilic functional group and a hydrophobic functional group at the same tim…
Who is the assignee on this patent?
Lg Chemical Ltd
What technology area does this patent fall under?
Primary CPC classification A01N33/12. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Aug 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).